Blossomhill Therapeutics earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BLSM earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$23.8M, up 13.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BLSM reported annual earnings of -$60.6M, with 97.3% growth.
BLSM earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
BLSM Return on Equity
Insufficient data to display
BLSM Return on Assets
Insufficient data to display
Be the first to know when BLSM announces earnings.
Blossomhill Therapeutics Earnings Reports & History FAQ
What were Blossomhill Therapeutics's earnings last quarter?
On BLSM's earnings call on Sep 18, 2026, Blossomhill Therapeutics (NASDAQ: BLSM) reported Q2 2026 earnings per share (EPS) of -$8.75, up 58.8% year over year. Total BLSM earnings for the quarter were -$23.76 million. In the same quarter last year, Blossomhill Therapeutics's earnings per share (EPS) was -$5.51.
Is Blossomhill Therapeutics profitable or losing money?
As of the last Blossomhill Therapeutics earnings report, Blossomhill Therapeutics is currently losing money. Blossomhill Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.
What was BLSM's earnings growth in the past year?
As of Blossomhill Therapeutics's earnings date in Sep 18, 2026, Blossomhill Therapeutics's earnings has grown year over year. BLSM earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.